Carmignac Portfolio Emerging Discovery FW GBP AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 6.5 | 20.0 | -17.2 | 10.9 | 9.2 | |
+/-Cat | -6.3 | 5.1 | -6.4 | -1.7 | 6.0 | |
+/-B’mrk | -7.2 | 11.2 | -10.9 | 1.3 | 7.0 | |
Category: Global Emerging Markets Small/Mid-Cap Equity | ||||||
Category Benchmark: Morningstar EM SMID TME NR USD |
Key Stats | ||
NAV 29/04/2024 | GBP 201.03 | |
Day Change | -0.11% | |
Morningstar Category™ | Global Emerging Markets Small/Mid-Cap Equity | |
IA (formerly IMA) Sector | Global Emerging Markets | |
ISIN | LU0992630086 | |
Fund Size (Mil) 29/04/2024 | EUR 110.34 | |
Share Class Size (Mil) 29/04/2024 | GBP 8.06 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 1.50% |
Investment Objective: Carmignac Portfolio Emerging Discovery FW GBP Acc |
The Sub-Fund’s objective is to outperform its reference indicator over a recommended investment horizon of five years. This Sub-Fund is an actively managed UCITS. The investment manager has discretion over the composition of its portfolio, subject to the stated investment objectives and policy. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Amol Gogate 01/02/2021 | ||
Xavier Hovasse 01/01/2011 | ||
Inception Date 15/11/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
50% MSCI EM Small NR USD , 50% MSCI EM Mid NR USD | Morningstar EM SMID TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Carmignac Portfolio Emerging Discovery FW GBP Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Juniper Hotels Ltd | Consumer Cyclical | 4.42 |
Kaspi.kz JSC ADS | Technology | 4.40 |
PB Fintech Ltd | Financial Services | 4.26 |
Max Healthcare Institute Ltd Ord... | Healthcare | 4.03 |
Entero Healthcare Solutions Ltd | Healthcare | 3.53 |
Increase Decrease New since last portfolio | ||
Carmignac Portfolio Emerging Discovery FW GBP Acc |